Next Article in Journal
Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges
Next Article in Special Issue
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”
Previous Article in Journal
Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review
Previous Article in Special Issue
Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(6), 839; https://doi.org/10.3390/pharmaceutics13060839
Action Date Notes Link
article xml file uploaded 7 June 2021 10:43 CEST Original file -
article xml uploaded. 7 June 2021 10:43 CEST Update https://www.mdpi.com/1999-4923/13/6/839/xml
article pdf uploaded. 7 June 2021 10:43 CEST Version of Record https://www.mdpi.com/1999-4923/13/6/839/pdf
article html file updated 7 June 2021 10:44 CEST Original file -
article html file updated 26 July 2022 23:09 CEST Update https://www.mdpi.com/1999-4923/13/6/839/html
Back to TopTop